We investigated a possible contribution of nitric oxide (NO) and prostaglandins to the inhibitory effect of losartan on contractions to Ang I (10 -6 M) and Ang II (10 -7 M) with or without L-NAME (10 -4 M) or indomethacin (10 -5 M) in the aorta of WKY, SHR and hamster (n=7 each). Rings of thoracic aorta (2-mm long) were placed in a myograph (5 ml). Endothelium-dependent vasodilations were evaluated with acetylcholine (10 -8~ 10 -6 M). After a 45-minute incubation with L-NAME under a resting tension of 2 g, only hamster aorta contracted (p<0.01). The SHR aorta showed impaired relaxations to acetylcholine compared with the WKY and hamster aorta (p<0.05). Despite the difference in the stimulated NO release, losartan completely abolished the responses to Ang I and Ang II both in WKY and SHR vessels irrespective of the presence of L-NAME. In contrast to the rat aorta, the inhibitory effect of losartan was attenuated in the presence of L-NAME in the hamster aorta (78% vs 99% inhibition, p<0.05). Indomethacin did not alter the effect of losartan in any vessels. Our results suggest that the presence of NO, particularly a basal secretion of NO, is necessary for the full expression of the inhibitory effect of losartan in the hamster, but not in WKY or SHR, aorta. Unlike NO, prostaglandins do not appear to play a role in the effect of losartan.
Introduction
Angiotensin (Ang) II subtype 1 receptor antagonists have been proved to be as effective as angiotensin converting enzyme (ACE) inhibitors in the treatment of hypertension. 1 In contrast to ACE inhibitors, the antihypertensive effect of Ang II receptor antagonists is generally attributed solely to the blockade of the interaction between Ang II and its type 1 (AT 1 ) receptors. To support this notion, long-term use of losartan in patients with hypertension did not induce cough, 1 a wellestablished side effect of ACE inhibitors probably related to increased levels of bradykinin.
However, additional mechanisms distinct from Ang II receptor antagonism, are also implicated. Losartan induced a prolonged antihypertensive effect in renin-dependent hypertensive rats despite intact pressor responses to Ang I and Ang II. 2 A nitric oxide (NO) synthase inhibitor antagonised acute blood pressure reduction with losartan in spontaneously hypertensive rats (SHR). 3 Losartan suppressed the contractile responses to prostaglandin F, 4 suggesting an interaction of losar-tan with prostaglandin receptors.
We therefore investigated a possible contribution of NO and prostaglandins to the inhibitory effect of losartan on the contractions to Ang I and Ang II in the aorta of WKY, SHR and hamster. Hamsters were used because hamster vessels have different Ang II-forming pathways compared with those of rats. [5] [6] [7] Materials and methods Animals Twenty two to 24-week-old male Syrian hamsters (n=7), and Wistar Kyoto rats/Izm (WKY) and SHR/Izm (n=7 each) were obtained from Japan SLC (Shizuoka, Japan) and the Disease Model Cooperative Research Association (Kyoto, Japan), respectively.They were kept in a quiet room at constant temperature (20-22˚C) and under a 12:12 hour light-dark cycle. The experiments were performed in accordance with the institutional guidelines of the Osaka Medical College for the use of experimental animals. Blood pressure in conscious rats was measured with the tail-cuff method.
Isolated vessel study
The methods for the isolated vessel study have been detailed elsewhere. 5 Briefly, under anaesthesia with 4% chloral hydrate (350 mg/kg, i.p.), the thoracic aorta was excised and four rings (2-mm long) were placed in a Mulvany myograph containing 5 ml Krebs solution. The baths were continuously gassed with 95% O2/5% CO 2 and kept at 37˚C (pH 7.4). After a 45-minute incubation with 2 g resting tension, the aortic rings were stimulated twice with KCl (50 mM).Then the inhibitory effects of losartan (10 -5 M) on the contractile response to Ang I (10 -6 M) and Ang II (10 -7 M) were assessed with or without N G -nitro-L-arginine methyl ester (L-NAME) (10 -4 M) or indomethacin (10 -5 M).To compare the effect of losartan with another Ang II receptor antagonist, the same protocol was repeated with candesartan (10 -6 M). This concentration was chosen because candesartan is 10 times more potent than losartan. 8 In a separate set of rings, the endothelium-dependent and independent vasodilations were evaluated with acetylcholine (10 -8~ 10 -6 M) and sodium nitroprusside (10 -8~ 10 -6 M), respectively. Using haematoxylin and eosin staining, we confirmed the presence of the endothelium.
Drugs
Phenylephrine, L-NAME, indomethacin, sodium 
Statistics
Data are expressed as percent of the submaximal contraction induced by phenylephrine (10 -6 M). Statistical evaluation was done by Student's t-test for paired and unpaired observations. Values are expressed as mean ± SEM. A p-value <0.05 was considered statistically significant.
Results
Blood pressure of conscious SHR was significantly higher than that of WKY (214 ± 16 vs 136 ± 12 mmHg, p<0.01). Blood pressure was not measured in hamsters. There were no differences in the responses to KCL and phenylephrine among the groups; losartan did not affect the contractions to KCL and phenylephrine (data not shown).
After a 45-minute incubation with L-NAME under a resting tension of 2 g, no active tension developed in the aorta of WKY and SHR; however, the hamster aorta contracted significantly ( Figure  1 ), suggesting a greater basal release of NO in the hamster vessels compared with those of rats.
The endothelium-dependent relaxations to acetylcholine in the SHR aorta were significantly impaired compared with those of the WKY and hamster aorta (Figure 2 ), suggesting a decreased stimulated release of NO in the aorta of SHR. In contrast, the endothelium-independent relaxations in response to sodium nitroprusside did not differ between the groups (Figure 3 ).
Despite the difference in the stimulated NO release in the WKY and SHR aorta, losartan completely abolished the contractile responses to Ang I and Ang II both in WKY and SHR vessels irrespective of the presence of L-NAME (Figure 4 ;Ang II data not shown). In contrast to the rat aorta, the inhibitory effect of losartan was attenuated in the PAPER Figure 1 The increase in contraction (∆ contraction) after 45-minute incubation with L-NAME in the aorta of WKY, SHR and hamsters. Only hamster aorta contracted significantly. *p<0.05 vs resting tension. presence of L-NAME in the hamster aorta ( Figure  4 ). To clarify whether these findings are specific for losartan, we repeated the experiment with candesartan, and found similar results (data not shown). Unlike L-NAME, indomethacin did not contract any vessels or affect the effect of losartan (data not shown).
Discussion
The aorta of hamsters, but not of SHR and WKY, significantly contracted with L-NAME, suggesting that a basal NO secretion in the hamster aorta is greater compared with the WKY and SHR aorta. This may explain why L-NAME attenuated the inhibitory effect of losartan on the Ang I-and Ang II-induced contractions only in the hamster aorta. Although the endothelium-dependent relaxations to acetylcholine were impaired in SHR compared with WKY, losartan completely suppressed the contractions to Ang I and Ang II to a similar degree in WKY and SHR even in the presence of L-NAME.
Thus, a basal NO release appears to be necessary for the full expression of the inhibitory effect of losartan in hamster, but not in WKY or SHR, aorta. Although candesartan has a more potent inhibitory effect than losartan, 8 even candesartan could not completely suppress the contractions to angiotensins in hamster aorta in the presence of L-NAME. These findings suggest the presence of species difference in the effectiveness of Ang II receptor antagonists. The inhibitory effects of losartan on the contractions to angiotensins could be specific for these peptides in our experimental settings because losartan had no effect on KCLand phenylephrine-induced contractions in the aorta of SHR, WKY and hamsters. Although we used only the aorta, Corriu et al. 4 showed similar inhibitory characteristics of losartan both in rat aorta and mesenteric arteries. L-NAME did not contract the isolated aorta of SHR and WKY in our study. This is in contrast to the in vivo finding that one-week administration Figure 3 Endothelium-independent relaxations to sodium nitroprusside (SNP).There were no differences among the groups.
Figure 4
Inhibitory effect of losartan on the contractions to Ang I in the presence of L-NAME. Losartan completely suppressed the contractions in the aorta of WKY and SHR. However, the inhibitory effect was attenuated in the hamster aorta. *p<0.05 vs WKY and SHR. of L-NAME significantly increased blood pressure in SHR. 9 Several reasons can be postulated to explain the difference. First, we used the aorta, a conductance vessel, which may not participate in blood pressure regulation. Like the aorta, rat carotid arteries did not respond to L-NAME (our unpublished observation). Secondly, we observed the acute response to L-NAME in the isolated vessel, while others evaluated a more prolonged response in vivo. Interestingly, concurrent administration of L-NAME and losartan increased blood pressure in SHR, while losartan alone showed significant hypotensive effect. 9 These findings strongly suggest that NO plays an important role in the hypotensive effect of losartan in SHR, even though the stimulated release of NO is impaired in these animals as shown in the present study. Unlike rat vessels, hamster arteries possess an ACE-independent Ang II-forming pathway. [5] [6] [7] However, this does not diminish the effect of losartan since losartan inhibited the contractions induced by Ang I and Ang II to the same extent in the hamster aorta. Although some investigators have speculated that losartan may have an inhibitory effect on ACE, 2,10 our results indicate that this is not the case.
Journal of the Renin-Angiotensin-Aldosterone System
In our study, indomethacin affected neither the resting tension nor the inhibitory characteristics of losartan in rat and hamster aorta. In agreement with our findings, indomethacin did not affect basal blood pressure in conscious SHR. 9 However, these authors showed that indomethacin attenuated, but did not reverse, the hypotensive effect of losartan in SHR.Thus, prostaglandins appear to be less important than NO in the hypotensive effect of losartan. Likewise, bradykinin may not play a role in the effectiveness of losartan since, unlike enalapril, 11 losartan did not increase blood flow in the human forearm after an infusion of bradykinin.
The results of our group and others 2,3 suggest that losartan has more complex mechanisms of action than originally thought. Well-known side effects of ACE inhibitors such as angioedema and bronchospasm, presumably related to increased bradykinin levels, are also reported with the use of losartan. 12, 13 Further studies are warranted to elucidate the mechanisms underlying these sideeffects.
In conclusion, our findings suggest that the presence of NO, particularly a basal NO release, is necessary for the full expression of the inhibitory characteristics of losartan in hamster, but not in WKY or SHR, aorta. Similar findings were found with candesartan. Thus, there appears to be the presence of species difference in the effectiveness of Ang II receptor antagonists. Unlike NO, prostaglandins do not appear to play a role in the inhibitory characteristics of losartan in the isolated vessels.
